Regeneron Pharmaceuticals | REGN - 税前利润

股票价格
723.57
每天变化
21.30 3.03%
每月一次
-5.17%
每年
29.55%
Q2 预测
686.83




税前利润 更改 日
AbbVie USD 5.57B 2.9B 2026-03
Agenus USD -10.61M 263.52M 2025-12
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Alnylam Pharmaceuticals USD 221.65M 60.52M 2026-03
Amgen USD 1.51B 2.41B 2025-12
Astellas Pharma JPY 48.02B 85.93B 2026-03
AstraZeneca USD 3.91B 1.28B 2026-03
Biogen USD 377.7M 433.7M 2026-03
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Eli Lilly USD 8.27B 1.03B 2025-12
Esperion Therapeutics USD 63.67M 95M 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
Incyte USD 343.6M 46.34M 2026-03
Ionis Pharmaceuticals USD -93M 135M 2026-03
J&J USD 7.82B 2.86B 2026-03
Kyowa Hakko Kirin JPY 39.3B 13.35B 2025-12
Merck USD 3.42B 3.32B 2025-12
Moderna USD -799M 612M 2025-12
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
Novartis USD 3.84B 802M 2026-03
Novartis USD 5.17B 637M 2025-09
Pfizer USD 5.18B 6.82B 2026-03
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 6.23B 2025-12
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Teva Pharmaceutical Industries USD 753M 662M 2026-03
Ultragenyx Pharmaceutical USD -184M 56M 2026-03
United Therapeutics USD 444M 6M 2025-12
Vertex Pharmaceuticals USD 1.33B 32.2M 2025-12